Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
出版年份 2022 全文链接
标题
Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies
作者
关键词
-
出版物
Neurology and Therapy
Volume 12, Issue 1, Pages 1-10
出版商
Springer Science and Business Media LLC
发表日期
2022-11-29
DOI
10.1007/s40120-022-00421-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
- (2022) Kerstin Hellwig et al. JAMA Network Open
- Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids
- (2022) Kiran Ninan et al. JAMA Pediatrics
- Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population
- (2022) Johanna Balslev Andersen et al. Multiple Sclerosis and Related Disorders
- Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
- (2022) Ruth Dobson et al. Practical Neurology
- Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
- (2022) Doriana Landi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Use of disease-modifying drugs during pregnancy and breastfeeding
- (2021) Ruth Dobson et al. CURRENT OPINION IN NEUROLOGY
- Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies
- (2021) Hélène Tillaut et al. Multiple Sclerosis Journal
- Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening
- (2021) Emilio Portaccio et al. Multiple Sclerosis Journal
- Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
- (2021) Assunta Bianco et al. Neurotherapeutics
- Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists
- (2021) Gustavo Saposnik et al. Multiple Sclerosis and Related Disorders
- “I'm walking into the unknown”: Qualitative insights into how emotions and lived experience related to multiple sclerosis diagnosis impact on decisions to pursue disease modifying treatment
- (2021) Gina Carey et al. Multiple Sclerosis and Related Disorders
- Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry
- (2021) Kerstin Hellwig et al. Neurology-Neuroimmunology & Neuroinflammation
- First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations
- (2020) Per Damkier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry
- (2020) Kerstin Hellwig et al. JOURNAL OF NEUROLOGY
- Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
- (2020) Andrea Ines Ciplea et al. Neurology-Neuroimmunology & Neuroinflammation
- Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions
- (2019) Kristen M. Krysko et al. Neurology-Neuroimmunology & Neuroinflammation
- Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: Analysis of predisposing factors
- (2019) Maria Sepúlveda et al. Multiple Sclerosis and Related Disorders
- Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy: Response rate and complication
- (2018) Xue Xu et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Pregnancy decision-making in women with multiple sclerosis treated with natalizumab
- (2018) Emilio Portaccio et al. NEUROLOGY
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Adverse Effects of Immunoglobulin Therapy
- (2018) Yi Guo et al. Frontiers in Immunology
- Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS
- (2018) Maria K. Houtchens et al. NEUROLOGY
- Pregnancy rates and outcomes in women with and without MS in the United States
- (2018) Maria K. Houtchens et al. NEUROLOGY
- Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
- (2016) Sandra Thiel et al. Multiple Sclerosis Journal
- Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
- (2016) Sandra Thiel et al. Multiple Sclerosis Journal
- Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis
- (2015) Teresa E. Baker et al. JOURNAL OF HUMAN LACTATION
- Sex and gender issues in multiple sclerosis
- (2013) Hanne F. Harbo et al. Therapeutic Advances in Neurological Disorders
- Pregnancy outcomes after in utero exposure to Baclofen
- (2012) Nathalie Bernard et al. REPRODUCTIVE TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started